Advisor Group Holdings, Inc. Macrogenics Inc Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Macrogenics Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 7,175 shares of MGNX stock, worth $10,762. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,175

Previous 7,345 2.31%

Holding current value

$10,762

Previous $8,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	SELL	$1.06 - $1.79 $180 - $304	-170 Reduced 2.31%	7,175 $8,000
Q1 2025 May 12, 2025	SELL	$1.26 - $3.49 $651 - $1,804	-517 Reduced 6.58%	7,345 $9,000
Q4 2024 Jun 06, 2025	BUY	$3.18 - $4.46 $372 - $521	117 Added 1.59%	7,462 $24,000
Q4 2024 Feb 07, 2025	BUY	$3.18 - $4.46 $419 - $588	132 Added 1.71%	7,862 $25,000
Q3 2024 Nov 13, 2024	SELL	$3.0 - $5.55 $120 - $222	-40 Reduced 0.51%	7,730 $25,000
Q2 2024 Aug 13, 2024	BUY	$3.31 - $18.51 $25,718 - $143,822	7,770 New	7,770 $33,000
Q4 2023 Feb 12, 2024	SELL	$4.48 - $10.11 $1,576 - $3,558	-352 Reduced 87.56%	50 $0
Q3 2023 Nov 13, 2023	BUY	$4.48 - $6.19 $224 - $309	50 Added 14.2%	402 $1,000
Q2 2023 Aug 10, 2023	SELL	$4.62 - $7.54 $205,248 - $334,972	-44,426 Reduced 99.21%	352 $1,000
Q1 2023 May 12, 2023	SELL	$4.82 - $7.24 $259,643 - $390,004	-53,868 Reduced 54.61%	44,778 $321,000
Q4 2022 Feb 10, 2023	BUY	$3.34 - $6.98 $327,700 - $684,835	98,114 Added 18442.48%	98,646 $661,000
Q3 2022 Nov 14, 2022	BUY	$3.01 - $5.22 $397 - $689	132 Added 33.0%	532 $2,000
Q2 2022 Aug 10, 2022	SELL	$2.25 - $9.99 $855 - $3,796	-380 Reduced 48.72%	400 $2,000
Q1 2022 May 04, 2022	SELL	$8.12 - $16.9 $7,916 - $16,477	-975 Reduced 55.56%	780 $6,000
Q3 2021 Nov 05, 2021	SELL	$19.74 - $28.7 $21,950 - $31,914	-1,112 Reduced 38.79%	1,755 $36,000
Q2 2021 Aug 02, 2021	BUY	$20.49 - $35.63 $819 - $1,425	40 Added 1.41%	2,867 $78,000
Q1 2021 May 13, 2021	BUY	$18.99 - $33.2 $27,820 - $48,638	1,465 Added 107.56%	2,827 $90,000
Q4 2020 Feb 10, 2021	BUY	$19.41 - $26.0 $15,683 - $21,008	808 Added 145.85%	1,362 $31,000
Q2 2020 Aug 14, 2020	SELL	$5.2 - $29.12 $17,399 - $97,435	-3,346 Reduced 85.79%	554 $16,000
Q1 2020 May 18, 2020	BUY	$4.28 - $12.11 $16,692 - $47,229	3,900 New	3,900 $22,000

Others Institutions Holding MGNX

# of Institutions

117

Shares Held

52.5M

Call Options Held

55.3K

Put Options Held

35.9K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $92.2M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Macrogenics Inc Transaction History